Contraceptive prevalence, any modern method in Kazakhstan
Kazakhstan: Contraceptive prevalence, any modern method was 50.1% in 2018. ▲ Rising
Contraceptive prevalence, any modern method in Kazakhstan, 1995–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Kazakhstan is 50.1%, measured in 2018.
Compared with earlier readings it is down 6.5% on the previous year and up 1.4% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Kazakhstan peaked at 53.6% in 2015 and was at its lowest, 46.1%, in 1995.
Kazakhstan ranks 51st of 113 countries on this measure, in the middle of the range.
Contraceptive prevalence, any modern method in Kazakhstan, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1995 | 46.1% | — |
| 1999 | 52.8% | +14.5% |
| 2006 | 49.4% | -6.4% |
| 2011 | 49.7% | +0.7% |
| 2015 | 53.6% | +7.8% |
| 2018 | 50.1% | -6.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 49.5% | 46.1% | 52.8% | 2 |
| 2000s | 49.4% | 49.4% | 49.4% | 1 |
| 2010s | 51.1% | 49.7% | 53.6% | 3 |
Countries ranked near Kazakhstan
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Kazakhstan?
- Contraceptive prevalence, any modern method in Kazakhstan was 50.1% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Kazakhstan?
- The highest recorded value was 53.6% in 2015.
- What is the lowest contraceptive prevalence, any modern method recorded in Kazakhstan?
- The lowest recorded value was 46.1% in 1995.
- How does Kazakhstan rank for contraceptive prevalence, any modern method?
- Kazakhstan ranks 51st out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Kazakhstan?
- Over the last ten years it is up 1.4%. The long-run trend across the full record is rising.
- Where does this Kazakhstan data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.